Low Risk of Hypoglycemia : Unlike some other diabetes medications, semaglutide carries a low risk of causing hypoglycemia (low blood sugar), especially when not used with insulin or sulfonylureas
Were talking about preventing serious metabolic complications and addressing weight gain thats affecting quality of life and potentially adherence to necessary psychiatric medications
A sample routine might look like: AM: Cleanse, serum, moisturiser, sunscreen
Annual pharmacy cost per patient achieving composite treatment endpoints: a cost to target analysis of GLP-T versus GLP-S semaglutide 1 mg in patients with type 2 diabetes in the UK
Since July 2024, Wegovy is also licensed by the MHRA to reduce the risk of serious cardiovascular events (heart attack, stroke) in adults with established cardiovascular disease and a body mass index (BMI) of 27 or above
Weight loss is a personal journey